• Simone M C Spoorenberg, Stefan M T Vestjens, G P Voorn, van Moorsel Coline H M CHM Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands. , Bob Meek, Pieter Zanen, Ger T Rijkers, Bos Willem Jan W WJW Department of Internal Medicine, St Antonius Hospital, Nieuwegein, The Netherlands., Jan C Grutters, and Ovidius study group.
• Department of Internal Medicine, St Antonius Hospital, Nieuwegein, The Netherlands.
• Plos One. 2018 Jan 1; 13 (1): e0190575.

Background And AimSP-D, YKL-40, CCL18 and CA 15-3 are pulmonary markers that have been extensively investigated in different chronic pulmonary diseases. However, in acute pulmonary diseases, such as community-acquired pneumonia (CAP), little is known about the course of these markers and their relationship with the aetiological agent. The aim of this study was to investigate the course of these four markers in CAP and to study influence of disease severity, aetiology and antibiotic use prior to admission on their course.MethodsWe included 291 adult patients hospitalised with CAP and 20 healthy controls. Measurements were performed in serum of day 0, 2, and 4, and at least 30 days after admission.ResultsOur most important results were: 1) At all time-points, including 30 days after admission, YKL-40 and CCL18 levels were higher in CAP patients compared to healthy controls; and 2) Patients with CAP caused by an intracellular, atypical bacterium had lower YKL-40 and especially CCL18 levels on and during admission in comparison with other or unknown CAP aetiology.ConclusionsOur findings suggest that these pulmonary markers could be useful to assess CAP severity and, especially YKL-40 and CCL18 by helping predict CAP caused by atypical pathogens.

24 keywords...

hide…